No7 unveils addition to targeted skin care solutions line
No7 is finally unveiling the first product in its new No7 Laboratories lineup of targeted skin care solutions.
The new No7 Laboratories Line Correcting Booster Serum looks to reduce the appearance of wrinkles by up to five years in as little as 12 weeks, according to a clinical study the company conducted on 31 women.
“No7 Laboratories Line Correcting Booster Serum is the first innovation launched under the No7 Laboratories brand, a new type of skin care, benefiting from No7 deep expertise, that pushes the boundaries of efficacy to deliver results that rival professional grade treatments,” Hilary Hutcheson, U.S. senior marketing director at No7, said. “We’re thrilled to introduce this ground-breaking innovation in the United States. This new serum generated a 17,000-person waitlist when it launched in the U.K., and we anticipate similar excitement here in the United States.”
Containing the brand’s most concentrated age-defying solution, the product also features No7’s anti-wrinkle peptide technology and higher concentrations of matrixyl 3000 plus, which helps skin recover such components as elastic fibrillin, the company said.
No7 Laboratories Line Correcting Booster Serum retails for $41.99 and will be available exclusively on Walgreens’ website in October before hitting the retailer’s shelves on Nov. 4.
In addition, the serum will hit Target and Ulta Beauty shelves in 2019.
No comments found